✦ LIBER ✦

Clinical and pathological implications ofGSTM1andGSTT1gene deletions in sporadic breast cancer

✍ Scribed by Cassio Cardoso Filho; Gustavo Lourenço; Julia Yoriko Shinzato; Luiz Carlos Zeferino; Fernando Ferreira Costa; Carmen Silvia Passos Lima; Maria Salete Costa Gurgel

Book ID: 107615944
Publisher: PAGEPress Publications
Year: 2008
Tongue: English
Weight: 98 KB
Volume: 2
Category: Article
ISSN: 1970-5557
DOI: 10.1007/s12156-008-0054-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble ICAM-1 in breast cancer: clinica

Soluble ICAM-1 in breast cancer: clinical significance and biological implications

✍ Wolfgang J. Köstler; Sandra Tomek; Thomas Brodowicz; Alexandra C. Budinsky; Mari 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

Somatic mutations in the BRCA1 gene in C

Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer

✍ Khoo, Ui-Soon; Ozcelik, Hilmi; Cheung, Annie NY; Chow, Louis WC; Ngan, Hextan YS 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 233 KB

Analysis of Loss of heterozygosity and i

Analysis of Loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers

✍ Kada Peela Bheeman Dinesh; Halagowder Devaraj; Vadivel Murugan; Ramamurthy Rajar 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 178 KB

Pathological, clinical and prognostic ch

Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa

✍ K D Awadelkarim; C Arizzi; E O M Elamin; H M A Hamad; P De Blasio; S O Mekki; I 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Identification of missense and truncatin

Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

✍ Jill Greenman; Shehla Mohammed; David Ellis; Sally Watts; Gillian Scott; Louise 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The cloning of the breast and ovarian cancer susceptibility gene, BRCA1, allows direct estimation of the proportion of these cancers in the general population which can be attributed to germline mutations in this gene. We have used a combination of SSCP, heteroduplex analysis, and chemical cleavage

RASSF1A gene inactivation in non-small c

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication

✍ Hideki Endoh; Yasushi Yatabe; Shigeki Shimizu; Kohei Tajima; Hiroyuki Kuwano; Ta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 227 KB 👁 1 views

## Abstract Methylation‐associated inactivation of __RASSF1__, a putative tumor suppressor identified at 3p21.3, is reported in several cancers. We examined __RASSF1__ in non‐small lung cancer (NSCLC) to search for clinical implications. RT‐PCR analysis showed no expression of __RASSF1A__ in 12 of